palladium has been researched along with Edema in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (29.17) | 18.2507 |
2000's | 12 (50.00) | 29.6817 |
2010's | 4 (16.67) | 24.3611 |
2020's | 1 (4.17) | 2.80 |
Authors | Studies |
---|---|
Bhuvaneswari, S; Umadevi, M; Vanajothi, R | 1 |
Hamada, Y; Kitaura, K; Kumagai, K; Matsubara, R; Nakasone, Y; Shigematsu, H; Suzuki, R; Suzuki, S | 1 |
Ali, H; Atiq, A; Khan, A; Khan, S; Khan, SZ; Naveed, M; Shal, B; Ullah, R; Zeeshan, S | 1 |
Hosny, NM; Sherif, YE | 1 |
Beaulieu, L; Leclerc, G; Lessard, E; Pouliot, J; Villeneuve, M | 1 |
Lucas, S; Nuttens, VE | 1 |
Ahmad, S; Algan, O; Ali, I; Sindhwani, P; Thompson, S | 1 |
Garden, R; Gejerman, G; Lanteri, V; Mullokandov, E; Rosen, J; Saini, AJ; Sawczuk, I; Scheuch, J; Vitenson, J | 1 |
Kal, HB; Van Gellekom, MP | 1 |
Byrne, SF; Finger, PT; Moshfeghi, DM; Perry, HD | 1 |
Bice, WS; Kiefer, EJ; Prestidge, BR; Prete, JJ | 1 |
Corn, BW; Dicker, AP; Waterman, FM; Yue, N | 1 |
Corn, BW; Dicker, AP; Nath, R; Waterman, FM; Yue, N | 1 |
Dicker, AP; Nath, R; Waterman, FM; Yue, N | 1 |
Dicker, AP; Waterman, FM | 1 |
Chen, Z; Dicker, AP; Nath, R; Peschel, R; Waterman, FM; Yue, N | 1 |
Potters, L; Wang, XH; Yamada, Y | 1 |
Butler, WM; Coram, RJ; Dorsey, AT; Lief, JH; Merrick, GS | 1 |
Kovala-Demertzi, D | 1 |
Butler, WM; Dorsey, AT; Lief, JH; Merrick, GS | 1 |
Chen, Z; Nath, R; Peschel, R; Roberts, KB; Wang, X; Yue, N | 1 |
Chen, Z; Nath, R; Yue, N | 1 |
Battermann, JJ; Kal, HB; Moerland, MA; Van Gellekom, MP | 1 |
Dogan, N; Flanigan, RC; Glasgow, GP; Keys, K; Mohideen, N | 1 |
1 trial(s) available for palladium and Edema
Article | Year |
---|---|
Influence of prophylactic dexamethasone on edema following prostate brachytherapy.
Topics: Brachytherapy; Dexamethasone; Edema; Glucocorticoids; Humans; Iodine Radioisotopes; Male; Palladium; Perineum; Prostate; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2000 |
23 other study(ies) available for palladium and Edema
Article | Year |
---|---|
Effects on anti-inflammatory, DNA binding and molecular docking properties of 2-chloroquinolin-3-yl-methylene-pyridine/pyrazole derivatives and their palladium(II) complexes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cattle; Coordination Complexes; DNA; Dose-Response Relationship, Drug; Drug Discovery; Edema; Molecular Docking Simulation; Molecular Structure; Palladium; Pyrazoles; Pyridines; Rats; Rats, Wistar; Schiff Bases; Structure-Activity Relationship | 2020 |
Fexofenadine Suppresses Delayed-Type Hypersensitivity in the Murine Model of Palladium Allergy.
Topics: Allergens; Animals; Anti-Allergic Agents; Antigen-Presenting Cells; Biomarkers; Cytokines; Disease Models, Animal; Edema; Female; Histamine H1 Antagonists, Non-Sedating; Hypersensitivity, Delayed; Mice; Palladium; Prednisolone; Signal Transduction; T-Lymphocyte Subsets; Terfenadine | 2017 |
A new cationic palladium(II) dithiocarbamate exhibits anti-inflammatory, analgesic, and antipyretic activities through inhibition of inflammatory mediators in in vivo models.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antipyretics; Behavior, Animal; Cell Survival; Cytokines; Edema; Fever; Hyperalgesia; Inflammation; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Palladium; Thiocarbamates | 2019 |
Synthesis, structural, optical and anti-rheumatic activity of metal complexes derived from (E)-2-amino-N-(1-(2-aminophenyl)ethylidene)benzohydrazide (2-AAB) with Ru(III), Pd(II) and Zr(IV).
Topics: Amination; Animals; Anti-Inflammatory Agents; Benzene Derivatives; Coordination Complexes; Edema; Hydrazines; Lower Extremity; Models, Molecular; Palladium; Rats, Sprague-Dawley; Ruthenium; Zirconium | 2015 |
Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants.
Topics: Algorithms; Brachytherapy; Cesium Radioisotopes; Edema; Equipment Design; Half-Life; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy Planning, Computer-Assisted; Time Factors | 2008 |
Determination of the prescription dose for biradionuclide permanent prostate brachytherapy.
Topics: Brachytherapy; Cell Survival; Cesium Radioisotopes; Edema; Humans; Iodine Radioisotopes; Male; Models, Statistical; Models, Theoretical; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage | 2008 |
Dosimetric consideration of transient volume enlargement induced by edema in prostate brachytherapy seed implants.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Seeds; Tomography, X-Ray Computed | 2013 |
The effects of edema on urethral dose following palladium-103 prostate brachytherapy.
Topics: Brachytherapy; Dose-Response Relationship, Radiation; Edema; Humans; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed; Urethra; Urethral Diseases | 2002 |
How low is the alpha/beta ratio for prostate cancer?
Topics: Brachytherapy; DNA Repair; Edema; Humans; Iodine Radioisotopes; Linear Models; Male; Palladium; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Reference Values; Relative Biological Effectiveness | 2003 |
Retrobulbar oedema after ophthalmic plaque radiotherapy.
Topics: Aged; Brachytherapy; Choroid Neoplasms; Edema; Eye Diseases; Humans; Iodine Radioisotopes; Male; Melanoma; Palladium; Radioisotopes | 1993 |
Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Topics: Adenocarcinoma; Brachytherapy; Dose-Response Relationship, Radiation; Edema; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 1998 |
Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radiography; Radiotherapy Dosage; Time Factors | 1998 |
A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Models, Biological; Movement; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed | 1999 |
The impact of edema on planning 125I and 103Pd prostate implants.
Topics: Brachytherapy; Dose-Response Relationship, Radiation; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Time Factors | 1999 |
Effect of post-implant edema on the rectal dose in prostate brachytherapy.
Topics: Brachytherapy; Cohort Studies; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Diseases; Prostatic Neoplasms; Radiation Dosage; Radiopharmaceuticals; Rectum; Tomography, X-Ray Computed | 1999 |
Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Topics: Brachytherapy; Edema; Half-Life; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Time Factors | 1999 |
A nomogram to compensate for intraoperative prostate edema during transperineal brachytherapy.
Topics: Adenocarcinoma; Aged; Algorithms; Brachytherapy; Edema; Endosonography; Humans; Intraoperative Complications; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Perineum; Prospective Studies; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Rectum; Tomography, X-Ray Computed | 2000 |
Transition metal complexes of diclofenac with potentially interesting anti-inflammatory activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cobalt; Copper; Crystallography, X-Ray; Diclofenac; Edema; Electrochemistry; Iron; Manganese; Metals, Heavy; Models, Molecular; Molecular Conformation; Molybdenum; Nickel; Palladium | 2000 |
Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
Topics: Biophysical Phenomena; Biophysics; Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted | 2000 |
Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Models, Biological; Palladium; Physical Phenomena; Physics; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage | 2000 |
Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
Topics: Brachytherapy; Cell Survival; Edema; Humans; Iodine Radioisotopes; Male; Models, Theoretical; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy; Time Factors | 2002 |
Biologically effective dose for permanent prostate brachytherapy taking into account postimplant edema.
Topics: Algorithms; Brachytherapy; Edema; Gold Radioisotopes; Half-Life; Humans; Iodine Radioisotopes; Linear Models; Male; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioactivity; Radioisotopes; Relative Biological Effectiveness; Time Factors | 2002 |
Effect of prostatic edema on CT-based postimplant dosimetry.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Physical Phenomena; Physics; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rectum; Tomography, X-Ray Computed; Urinary Bladder | 2002 |